Summit Therapeutics Inc.
SMMT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $239 | $298 | $212 | $105 |
| Short-Term Investments | $0 | $0 | $150 | $307 |
| Receivables | $0 | $0 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $11 | $9 | $11 |
| Total Curr. Assets | $246 | $309 | $371 | $424 |
| Property Plant & Equip (Net) | $6 | $6 | $7 | $7 |
| Goodwill | $2 | $2 | $2 | $2 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $7 | $4 | $3 |
| Total NC Assets | $15 | $15 | $13 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $262 | $324 | $384 | $436 |
| Liabilities | – | – | – | – |
| Payables | $22 | $23 | $5 | $5 |
| Short-Term Debt | $3 | $3 | $4 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $40 | $34 | $26 | $33 |
| Total Curr. Liab. | $65 | $60 | $35 | $42 |
| LT Debt | $3 | $2 | $3 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $2 | $2 | $2 |
| Total NC Liab. | $5 | $4 | $5 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $2 | $3 | $7 |
| Total Liabilities | $69 | $65 | $39 | $47 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $7 | $7 | $7 | $7 |
| Retained Earnings | -$2,075 | -$1,843 | -$1,277 | -$1,215 |
| AOCI | -$3 | -$3 | -$3 | -$2 |
| Other Equity | $2,263 | $2,098 | $1,617 | $1,598 |
| Total Equity | $192 | $259 | $344 | $389 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $262 | $324 | $384 | $436 |
| Net Debt | -$233 | -$292 | -$205 | -$98 |